# Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian Population

> **NCT01782469** · — · TERMINATED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 16 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01782469
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Study stopped due to low enrollment
- **Last updated:** 2015-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01782469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01782469, "Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian Population". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01782469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*